Telomerase activity in ovarian tumors

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Telomere shortening limits cell division, leading to cell death.
• Telomerase, an enzyme that elongates telomeres, is active in germ cells, cancer cells, and immortal cell lines, but not normal somatic cells.
• Investigating telomerase expression in ovarian carcinogenesis is crucial.

Purpose of the Study:

• To investigate the relationship between telomerase expression and ovarian carcinogenesis.
• To evaluate telomerase activity and telomere length in various ovarian tumors.

Main Methods:

• Ovarian tissues from 41 women with ovarian tumors (benign, borderline-malignant, malignant) and 6 with uterine disease were analyzed.
• Telomeric repeat amplification protocol (TRAP) was used to assess telomerase activity.
• Southern blot hybridization was employed to determine telomere length.

Main Results:

• Telomerase activity was found in 92% of malignant ovarian tumors, 16.7% of borderline-malignant tumors, and 20% of benign tumors (germ cell tumors).
• Weak telomerase activity was observed in normal ovarian cortex, attributed to follicles.
• Malignant and poorly differentiated tumors showed higher telomerase activity. Shorter telomere length (<8 kbp) was observed in advanced-stage malignant ovarian tumors.

Conclusions:

• Telomerase activity may serve as a valuable diagnostic marker for ovarian tumors.
• The findings support the role of telomerase in ovarian cancer development and progression.